The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
McAlister, 2004, Renal insufficiency and heart failure. Prognostic and therapeutic implications from a prospective cohort study, Circulation, 109, 1004, 10.1161/01.CIR.0000116764.53225.A9
Zalewski, 2007, No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis, Arterioscler Thromb Vasc Biol, 27, 2258, 10.1161/ATVBAHA.107.149633
McCullogh, 2004, Cardiovascular disease in chronic kidney disease from cardiologist's perspective, Curr Opin Nephrol Hypertens, 13, 591, 10.1097/00041552-200411000-00003
Santopinto, 2003, Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from global registry of acute coronary events (GRACE), Heart, 89, 1003, 10.1136/heart.89.9.1003
Kendrick, 2008, Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease, Nat Clin Pract Nephrol, 4, 672, 10.1038/ncpneph0954
Essig, 2008, Cardiovascular remodeling and extracellular fluid excess in early stages of chronic kidney disease, Nephrol Dial Transplant, 23, 239, 10.1093/ndt/gfm542
Beygui, 2006, Architecture of intracoronary thrombi in ST-elevation acute myocardial infarction, Circulation, 113, e21, 10.1161/CIRCULATIONAHA.105.551705
Blombäck, 1996, Fibrinogen and fibrin proteins with complex roles haemostasis and thrombosis, Thromb Res, 83, 1, 10.1016/0049-3848(96)00111-9
Scott, 2004, Genetic and environmental determinants of fibrin structure and function: relevance of clinical disease, Arterioscler Thromb Vasc Biol, 24, 1558, 10.1161/01.ATV.0000136649.83297.bf
Undas, 2008, Reduced clot permeability and suscepitiblitity to lysis in patients with acute coronary syndrome: effect of inflammation and oxidative stress, Atherosclerosis, 196, 551, 10.1016/j.atherosclerosis.2007.05.028
Collet, 2006, Altered fibrin architecture in association with hypofibrynolysis and premature coronary atherothrombosis, Arterioscler Thromb Vasc Biol, 26, 2567, 10.1161/01.ATV.0000241589.52950.4c
Fatah, 1992, Fibrin gel network characteristics and coronary artery disease: relationship to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis, Thromb Haemost, 68, 130, 10.1055/s-0038-1656337
Roberts, 2006, Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease, Am J Kidney Dis, 48, 341, 10.1053/j.ajkd.2006.06.005
Shlipak, 2003, Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency, Circulation, 107, 87, 10.1161/01.CIR.0000042700.48769.59
Sjoland, 2007, Fibrin clot structure in patients with end-stage renal disease, Thromb Haemost, 98, 339, 10.1160/TH06-12-0715
Undas, 2008, Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality, Nephrol Dial Transplant, 23, 2010, 10.1093/ndt/gfm884
Thygesen, 2007, White AD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction., Eur Heart J, 28, 2525, 10.1093/eurheartj/ehm355
Levey, 2005, Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO), Kidney Int, 67, 2089, 10.1111/j.1523-1755.2005.00365.x
Undas, 2006, Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary heart disease, J Thromb Haemost, 4, 973, 10.1111/j.1538-7836.2006.01903.x
von dem Borne, 1995, Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis, Blood, 86, 3035, 10.1182/blood.V86.8.3035.3035
Lisman, 2001, Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis, Gastroenterology, 121, 131, 10.1053/gast.2001.25481
Collet, 1999, Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications, Thromb Haemost, 82, 1482, 10.1055/s-0037-1614859
Undas, 2009, Systemic blood coagulation activation in acute coronary syndromes, Blood, 113, 2070, 10.1182/blood-2008-07-167411
Minutolo, 2008, Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy, Am J Kidney Dis, 52, 444, 10.1053/j.ajkd.2008.03.002
Krol, 2008, Early detection of chronic kidney disease: results of the PolNef Study, Am J Nephrol, 29, 264, 10.1159/000158526
Reddan, 2005, Renal function, concomitant medication use and outcomes following acute coronary syndromes, Nephrol Dial Transplant, 20, 2105, 10.1093/ndt/gfh981
Gibson, 2004, Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome, observations in 13307 patients in five TIMI trials, Eur Heart J, 25, 1998, 10.1016/j.ehj.2004.08.016
Levin, 2003, Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis, Semin Dial, 16, 101, 10.1046/j.1525-139X.2003.16025.x
Prigent, 2008, Monitoring renal failure and limitations of renal functional tests, Semin Nucl Med, 28, 32, 10.1053/j.semnuclmed.2007.09.003
Obermayer, 2008, Predictors of new-onset decline in kidney function in a general middle-European population, Nephrol Dial Transplant, 23, 1265, 10.1093/ndt/gfm790
Undas, 2007, Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine, J Thromb Haemost, 5, 1988, 10.1111/j.1538-7836.2007.02637.x
Wiman, 2000, Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand Factor are significant risk factors for recurrent myocardial infarction in Stockholm Heart Epidemiology Program (SHEEP) Study, Arterioscler Thromb Vasc Biol, 20, 2019, 10.1161/01.ATV.20.8.2019
Ridker, 1993, Endogenous tissue-type plasminogen activator and risk of myocardial infarction, Lancet, 341, 1165, 10.1016/0140-6736(93)90998-V
Undas, 2009, Simvastatin increase clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l, Pol Arch Med Wewn, 119, 354